Home › Companies › MIRATI THERAPEUTICS INC. › 2023-2024

MIRATI THERAPEUTICS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and MIRATI THERAPEUTICS INC.’s Form 8-K, filed 2023-12-13 (Item 5.07 on EDGAR). Page generated 04 October 2026.

5Reported items
255Asset managers
920Fund votes
2023-12-13Meeting date

Proxy season: 2023-2024

Explore MIRATI THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by MIRATI THERAPEUTICS INC.

These tallies are MIRATI THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2023-12-13 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

MIRATI THERAPEUTICS INC. — official shareholder meeting results, meeting held 2023-12-13
Ballot item	For	Against	Abstain	Withheld	Outcome
Proposal 1: The Merger Proposal	52,217,230	137,341	16,524	--	Majority: yes
Proposal 2: The Compensation Proposal	39,006,088	13,335,289	29,718	--	Majority: yes
Proposal 3: The Adjournment Proposal	48,128,381	4,221,145	21,569	--	Majority: yes

Source: MIRATI THERAPEUTICS INC., Form 8-K, filed with the SEC on 2023-12-13 — read the filing on EDGAR.

How asset managers voted at the MIRATI THERAPEUTICS INC. 2023-2024 meeting

Each item below shows how the 255 asset managers that disclosed a MIRATI THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of MIRATI THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, by non-binding, advisory vote, compensation that may be paid or become payable by Mirati to its named executive officers in connection with the Merger.

COMPENSATION

Combines 9 wordings of this item as funds reported it.

0.6% fund support · no official result

AGAINST 99.4%

The 246 asset managers below cast 0.6% of the shares they voted on this item FOR (35,086,644 for, 6,702,941,930 against).

FOR: 35,086,644 (0.5%)AGAINST: 6,702,941,930 (99.5%)ABSTAIN: 350 (0.0%)UNKNOWN: 2,211 (0.0%)

Largest asset managers voting on “To approve, by non-binding, advisory vote, compensation that may be paid or become payable by Mirati to its na” at MIRATI THERAPEUTICS INC., 2023-2024
Asset manager	For	Against	Vote
AQR Arbitrage LLC	0	3,484,000,000	Against
Maryland State Retirement & Pension System	0	2,904,000,000	Against
Meeder Advisory Services, Inc.	0	279,000,000	Against
New York Life	0	23,239,913	Against
EcoR1 Capital, LLC	6,757,519	0	For
RTW INVESTMENTS, LP	6,112,493	0	For
Vanguard	5,690,245	0	For
Avoro Capital Advisors LLC	4,992,830	0	For
State Street	4,833,069	16,616	For
BlackRock	70,378	3,080,681	Against
FARALLON CAPITAL MANAGEMENT LLC	1,488,964	0	For
Paradigm Biocapital Advisors LP	1,293,144	0	For
Fidelity	0	1,058,334	Against
GEODE CAPITAL MANAGEMENT, LLC	0	904,000	Against
Rock Springs Capital Management LP	0	835,776	Against
Charles Schwab	0	695,120	Against
T. Rowe Price	0	641,095	Against
Candriam S.C.A.	0	611,738	Against
Dimensional	0	602,191	Against
Affinity Asset Advisors, LLC	427,444	0	For
MERGER FUND	401,962	0	For
AllianceBernstein	0	382,693	Against
ARMISTICE CAPITAL, LLC	372,928	0	For
Pentwater Capital Management LP	0	356,832	Against
Melqart Asset Management (UK) Ltd	353,637	0	For

Showing the 25 largest of 246 asset managers. See all 246 in the interactive database.

2. TO APPROVE THE ADJOURNMENT OF THE SPECIAL MEETING TO A LATER DATE OR DATES, IF NECESSARY OR APPROPRIATE, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES TO ADOPT THE MERGER AGREEMENT AT THE TIME OF THE SPECIAL MEETING.

CORPORATE GOVERNANCE

Combines 2 wordings of this item as funds reported it.

76% fund support · no official result

FOR 76%AGAINST 24%

The 78 asset managers below cast 76% of the shares they voted on this item FOR (10,194,573 for, 3,247,052 against).

FOR: 10,194,573 (75.8%)AGAINST: 3,247,052 (24.1%)ABSTAIN: 13,571 (0.1%)

Largest asset managers voting on “TO APPROVE THE ADJOURNMENT OF THE SPECIAL MEETING TO A LATER DATE OR DATES, IF NECESSARY OR APPROPRIATE, TO SO” at MIRATI THERAPEUTICS INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
Vanguard	5,615,722	0	0	For
State Street	0	2,090,093	0	Against
BlackRock	1,397,419	0	0	For
Fidelity	44,363	828,165	0	Against
Dimensional	516,728	0	0	For
MERGER FUND	401,962	0	0	For
Charles Schwab	347,560	0	0	For
Calamos	277,972	0	0	For
T. Rowe Price	0	266,604	0	Against
TIAA	251,174	0	0	For
New York Life	239,913	0	0	For
ARBITRAGE FUNDS	202,267	0	0	For
Jackson National	100,902	0	0	For
Virtus	79,321	0	0	For
Direxion Shares ETF Trust	71,719	0	0	For
Aberdeen	65,490	0	0	For
AltShares Trust	61,010	0	0	For
Delaware/Macquarie	60,000	0	0	For
Guggenheim	40,730	0	0	For
Brighthouse	385	37,528	0	Against
JPMorgan	35,906	0	0	For
MASTER INVESTMENT PORTFOLIO	32,758	0	0	For
Lincoln Financial	28,059	0	0	For
Equitable	14,009	0	13,571	For
Nushares ETF Trust	24,978	0	0	For

Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.

3. To adopt the Agreement and Plan of Merger (the "Merger Agreement"), dated October 8, 2023, by and among Mirati Therapeutics, Inc. ("Mirati"), Bristol-Myers Squibb Company ("Parent") and Vineyard Merger Sub Inc., a wholly owned subsidiary of Parent ("Merger Sub"), including the form of contingent value rights agreement to be entered into at or immediately prior to the effective time of the Merger b

EXTRAORDINARY TRANSACTIONS

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.8%

The 66 asset managers below cast 100% of the shares they voted on this item FOR (13,008,638 for, 0 against).

FOR: 13,008,638 (99.9%)ABSTAIN: 13,571 (0.1%)

Largest asset managers voting on “To adopt the Agreement and Plan of Merger (the "Merger Agreement"), dated October 8, 2023, by and among Mirati” at MIRATI THERAPEUTICS INC., 2023-2024
Asset manager	For	Vote
Vanguard	5,615,722	For
State Street	2,090,093	For
BlackRock	1,397,419	For
Fidelity	872,528	For
Dimensional	516,728	For
MERGER FUND	401,962	For
Calamos	277,972	For
T. Rowe Price	266,604	For
TIAA	251,174	For
New York Life	239,913	For
ARBITRAGE FUNDS	202,267	For
Jackson National	100,902	For
Virtus	79,321	For
Direxion Shares ETF Trust	71,719	For
Aberdeen	65,490	For
AltShares Trust	61,010	For
Delaware/Macquarie	60,000	For
Guggenheim	40,730	For
Brighthouse	37,913	For
JPMorgan	35,906	For
MASTER INVESTMENT PORTFOLIO	32,758	For
Lincoln Financial	28,059	For
Nushares ETF Trust	24,978	For
AllianceBernstein	23,787	For
Transamerica	22,577	For

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

4. To adopt Agreement & Plan of Merger ("Merger Agreement"), dated 10/8/2023, by and among Mirati Therapeutics, Inc., Bristol- Myers Squibb Company ("Parent") and Vineyard Merger Sub Inc., a wholly owned subsidiary of Parent ("Merger Sub"), including the form of contingent value rights agreement to be entered into at or immediately prior to effective time of the Merger by Parent & a rights agent reas

EXTRAORDINARY TRANSACTIONS

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 14 asset managers below cast 100% of the shares they voted on this item FOR (432,818 for, 0 against).

FOR: 432,818 (100.0%)

Largest asset managers voting on “To adopt Agreement & Plan of Merger ("Merger Agreement"), dated 10/8/2023, by and among Mirati Therapeutics, I” at MIRATI THERAPEUTICS INC., 2023-2024
Asset manager	For	Vote
Charles Schwab	347,560	For
SEI	15,086	For
Morningstar Funds Trust	14,831	For
Gabelli	14,000	For
Neuberger Berman	11,512	For
Equitable	9,000	For
Nationwide	8,810	For
GDL FUND	7,000	For
Comstock Funds, Inc.	2,250	For
RBB FUND, INC.	1,104	For
Prudential/PGIM	936	For
NEW COVENANT FUNDS	429	For
Adviser Managed Trust	268	For
UNITED CAPITAL FINANCIAL ADVISORS, LLC	32	For

5. Advisory Vote on Golden Parachutes

SECTION 14A SAY-ON-PAY VOTES

94% fund support · no official result

FOR 94%

The 3 asset managers below cast 94% of the shares they voted on this item FOR (683,237 for, 39,832 against).

FOR: 683,237 (94.5%)AGAINST: 39,832 (5.5%)

Largest asset managers voting on “Advisory Vote on Golden Parachutes” at MIRATI THERAPEUTICS INC., 2023-2024
Asset manager	For	Against	Vote
ADAGE CAPITAL PARTNERS GP, L.L.C.	683,237	0	For
JPMorgan	0	39,333	Against
Desjardins Global Asset Management Inc.	0	499	Against

Largest MIRATI THERAPEUTICS INC. shareholders voting in 2023-2024

Ranked by the number of MIRATI THERAPEUTICS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting.

Top MIRATI THERAPEUTICS INC. shareholders by shares voted, 2023-2024
#	Asset manager	Shares voted
1	AQR Arbitrage LLC	3,484,000,000
2	Maryland State Retirement & Pension System	2,904,000,000
3	Meeder Advisory Services, Inc.	279,000,000
4	New York Life	23,239,913
5	EcoR1 Capital, LLC	6,757,519
6	RTW INVESTMENTS, LP	6,112,493
7	Vanguard	5,690,245
8	Avoro Capital Advisors LLC	4,992,830
9	State Street	4,849,685
10	BlackRock	3,151,059

Shown as share counts, not percentages: no shares-outstanding figure has been matched to MIRATI THERAPEUTICS INC. for the 2023-2024 season, so there is no denominator to divide by.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At MIRATI THERAPEUTICS INC.'s shareholder meeting held 2023-12-13, in the 2023-2024 proxy season, 255 asset managers reported how they voted in their SEC Form N-PX filings, covering 920 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. MIRATI THERAPEUTICS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, by non-binding, advisory vote, compensation that may be paid or become payable by… — the reporting funds cast 0.6% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

MIRATI THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page).